Breast cancer expresses well-characterized immunohistochemical markers (ER, PR, and HER2), proliferation markers (Ki-67), genomic markers (BRCA1, BRCA2, and PIK3CA), and immunologic markers (tumor-infiltrating lymphocytes) [2]. The gene discussed is ERBB2; the disease is breast carcinoma.